Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.5 (
cathepsin D
)
4,130
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The distribution and biochemical properties of the
renin
activity present in the dog brain were compared with those of the lysosomal enzyme
cathepsin D
. Renin and cathepsin activity were present in all brain regions studied, in association with high angiotensinase activity. Brain
renin
activity was partially purified by ammonium sulfate fractionation and Sephadex gel filtration, resulting in the removal of angiotensinase activity. The specific brain
renin
activity increased approximately one hundred times during this procedure;
cathepsin D
activity accompanied the brain
renin
activity throughout the purification and showed a similar increase in specific activity. The
renin
and cathepsin activity in the partially purified preparation behaved identically during isoelectric focusing. The partially purified
renin
and cathepsin activity exhibited saturation kinetics with their respective substrates and were without activity above pH 6.0. Both enzyme activities were irreversibly inhibited by the pepsin inhibitor pepstatin, in nanomolar concentrations. These data, in conjunction with the literature concerning brain cathepsin, suggest that the
renin
activity in brain is due to
cathepsin D
, and that this
renin
activity exhibited by
cathepsin D
may be of limited significance under physiological conditions.
...
PMID:Renin activity in dog brain: enzymological similarity to cathepsin D. 18 Dec 41
Pepstatin is a low molecular weight, potent inhibitor specific for acid proteases with a Ki value of about 10(-10)M for pepsin. The chemical structure of pepstatin is essentially a hexapeptide which contains two residues of an unusual amino acid, 4-amino-3-hydroxy-6-methylheptanoic acid (statine). The complete structure of pepstatin is isovaleryl-L-valyl-L-valyl-statyl-L-alanyl-statine. To study its mode of inhibition, we prepared several derivatives and measured their kinetics of inhibition. Both N-acetyl-statine and N-acetyl-alanyl-statine are competitive inhibitors for pepsin with Ki values of 1.2 x 10(-4)M and 5.65 x 10(-6)M, respectively. The Ki value for N-acetyl-valyl-statine is 4.8 x 10(-6)M. These statyl derivatives, therefore, are very strong inhibitors. The Ki value for N-acetyl-statine is 600-fold smaller than that of its structural analog N-acetyl-leucine. The derivative which contains two statyl residues in a tetrapeptide exhibits inhibitory properties which approach those of pepstatin itself. Other acid proteases, human pepsin, human gastricsin,
renin
,
cathepsin D
, the acid protease from R. chinensis and bovine chymosin, also are inhibited by pepstatin and its derivatives. We suggest that the statyl residue is responsible for the unusual inhibitory capability of pepstatin and that statine is an analog of the previously proposed transition state for catalysis by pepsin and other acid proteases.
...
PMID:Pepstatin inhibition mechanism. 33 90
Inactive human
renin
is found in amniotic fluid, plasma, and kidney and may be a renin precursor ("prorenin"). The mechanism of activation of inactive
renin
in vivo is not known. The present study examined the hypothesis that
cathepsin D
, a lysosomal pepsin-like endopeptidase may be capable of eliciting activation. Cathepsin D was incubated with inactive
renin
in human amniotic fluid at pH 4.8 and 22 C for 0-5 h. Marked activation occurred and the reaction displayed first order kinetics with respect to the concentration of
cathepsin D
. The initial velocity of conversion of inactive
renin
to active
renin
by
cathepsin D
was 0.007%/min/microgram
cathepsin D
. Under identical conditions, the initial velocity of conversion by pepsin was 0.18%/min/microgram pepsin. The 25-fold higher potency of pepsin compared with
cathepsin D
is in accordance with the recognized relative substrate affinities and catalytic efficiencies of the two enzymes. Inactive
renin
in human amniotic fluid seems to be similar to that found in human kidney and since
cathepsin D
is present in juxtaglomerular cells, this activation process may have physiological importance.
...
PMID:Activation of human inactive ("pro-") renin by cathepsin D and pepsin. 37 40
Antibodies were raised in rabbit against pure human
renin
. The antisera obtained are highly specific for human
renin
versus hog, dog and rat
renin
. They do not cross-react with acid proteases such as pepsin and human
cathepsin D
. A direct radioimunoassay is described for human
renin
in plasma and kidney extracts. 30 to 50 pg of enzyme (2.5 to 4 x 10(-5) Goldblatt units) are detected.
...
PMID:Direct radioimmunoassay of human renin. 44 94
The concept of a brain
renin
-angiotensin system originated with the observation that the components necessary for the formation of angiotensin II are present in the central nervous system. This observation has been confirmed and extended, and it is now frequently assumed that there is a functional brain
renin
-angiotensin system. However, careful analysis of the available evidence has revealed a number of significant problems. It appears that most of the
renin
-like activity measured in extracts of brain is due to the acid protease
cathepsin D
; this is unlikely to function as an
angiotensin-forming enzyme
in vivo. Experiments involving central administration of
renin
substrate have not provided convincing evidence for a significant
renin
-
renin
substrate interaction in vivo. Attempts to demonstrate the presence of angiotensin in the brain have been plagued with problems of specificity and it is still not clear if the peptide is actually present in the central nervous system. These problems do not rule out the possibility that there is a brain
renin
-angiotensin system, but more definitive evidence is required before it can be concluded that such a tensin system exists.
...
PMID:The brain renin-angiotensin system: a critical analysis. 45 11
1. Renin was purified 30 000-fold from rat kidneys by chromatography on DEAE-cellulose and SP-Sephadex, and by affinity chromatography on pepstatinyl-Sepharose. 2. The enzymatic properties of isorenin from rat brain, pseudorenin from hog spleen,
cathepsin D
from bovine spleen, and
renin
from rat kidneys were compared: Isorenin, pseudorenin and
cathepsin D
generate angiotensin from tetradecapeptide
renin
substrate with pH optima around 4.9,
renin
at 6.0. With sheep angiotensinogen as substrate, isorenin, pseudorenin and
cathepsin D
have similar pH profiles (pH optima at 3.9 and 5.5), in contrast to
renin
(pH optimum at 6.8). 3. The angiotensin-formation from tetradecapeptide by isorenin, pseudorenin and
cathepsin D
was inhibited by albumin, alpha-and beta-globulins. These 3 enzymes have acid protease activity at pH 3.2 with hemoglobin as the substrate. Renin is not inhibited by proteins and has no acid protease activity. 4. Renin generates angiotensin I from various angiotensinogens at least 100 000 times faster than isorenin, pseudorenin or
cathepsin D
, and 3000 000 times faster than isorenin when compared at pH 7.2 with rat angiotensinogen as substrate. 5. The 3 'non-
renin
' enzymes exhibit a high sensitivity to inhibition by pepstatin (Ki less than 5.10(-10) M), in contrast to
renin
(Ki approximately 6-10(-7) M), at pH 5.5. 6. It is concluded from the data that isorenin from rat brain and pseudorenin from hog spleen are closely related to, or identical with
cathepsin D
.
...
PMID:Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensin-forming enzymes. 62 74
Cathepsin D, purified from hog spleen, releases angiotensin I from tetradecapeptide
renin
substrate and from protein
renin
substrates purified from hog and human plasma. However, the enzyme does not act on the naturally occurring
renin
substrate as it exists in plasma nor on purified substrate in the presence of plasma. Cathepsin D releases angiotensin I quantitatively from tetradecapeptide
renin
substrate and does not further degrade the angiotensin I on prolonged incubation. The pH optimum for
cathepsin D
prolonged incubation. The pH optimum for
cathepsin D
acting on tetradecapeptide
renin
substrate is 4.5, and there is very low activity above pH 7. These properties are very similar to those of pseudorenin, an
angiotensin-forming enzyme
originally isolated from human kidney, indicating that
cathepsin D
and pseudorenin may be identical.
...
PMID:A comparison of the substrate specificities of cathepsin D and pseudorenin. 64 Oct 59
Human renal
renin
(EC 3.4.99.19) and pseudorenin were easily separated in a single step by affinity chromatography on hemoglobin-Sepharose-2B. Renin and pseudorenin were monitored by their actions on crude and partially purified hog protein
renin
substrates at neutral and acidic pH and on synthetic labelled polymeric
renin
substrate. Under the conditions employed (0.1 M sodium acetate (pH 3.5)/1 M sodium chloride at 4 degrees C)
renin
does not bind to the affinity adsorbent while pseudorenin is effectively bound and can be eluted only after raising the pH to 6.5. Pseudorenin-free
renin
prepared by this method is devoid of proteolytic activity toward hemoglobin. The chromatographic behaviour of renal pseudorenin on hemoglobin-Sepharose-2B is similar to that of
cathepsin D
.
...
PMID:Separation of human renal renin and pseudorenin by affinity chromatography on hemoglobin-Sepharose-2B. 65 43
1. A
renin
-like enzyme in aortic tissue of the spontaneously hypertensive rat was found to be a freely dissociable enzyme (saline homogenization) with an affinity for the
renin
inhibitor pepstatin. At neutral pH values, the enzyme was active in homologous plasma to produce angiotensin I, and therefore distinct from pseudorenin and
cathepsin D
. The arterial enzyme and semi-purified renal
renin
could not be distinguished on the basis of Km values by using homologous
renin
substrate 2. An inverse relationship between the aortic
renin
content of the spontaneously hypertensive rat and the progressive increase of systolic blood pressure was observed with age. In contrast to this strain of rat, aortic
renin
of the normotensive WKY strain did not decline with age. 3. Plasma
renin
concentration and the aortic
renin
content of the spontaneously hypertensive rat showed divergent changes in response to a blood pressure fall associated with acute diuretic therapy, chronic administration of hydrallazine and in some animals in response to chronic administration of propranolol. 4. A low sodium diet elevated both plasma and aortic
renin
and retarded the progressive increase of blood pressure in the spontaneously hypertensive rat. A high sodium diet accelerated the progress of hypertension with no effect on aortic or plasma
renin
. 5. Antihypertensive therapy (1--6 weeks), resulting in a lowering of conscious systolic blood pressure of the spontaneously hypertensive rat, consistently led to a decrease in aortic
renin
content.
...
PMID:Partial characterization of aortic renin in the spontaneously hypertensive rat and its interrelationship with plasma renin, blood pressure and sodium balance. 69 2
Cerebrospinal fluid (CSF) of rats contains high angiotensinogen concentrations. When 3500-fold purified
renin
from human brain was injected into the brain ventricles of rats, angiotensin I concentrations increased from undetectable levels to 147.9 +/- 18.8 fMol per ml CSF. In parallel, mean arterial blood pressure increased from 93 +/- 2.4 mm Hg to 107 +/- 3.7 mm Hg. The increase in blood pressure could be abolished by intraventricular administration of saralasin, a blocker of angiotensin II receptors. Intraventricular injection of
cathepsin D
had no effect on arterial blood pressure and the agiotensin I concentration in CSF remained below detection limits of the radioimmunoassay. We conclude that brain
renin
acts on endogenous brain angiotensinogen under physioloical in vivo conditions to form angiotensin I. The latter is converted to angiotensin II and leads to biological effects, i.e. increase of blood pressure.
...
PMID:In vivo enzyme activity of purified human brain renin. 73 51
1
2
3
4
5
6
7
8
9
10
Next >>